Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Interv Neuroradiol ; 29(4): 459-465, 2023 Aug.
Article En | MEDLINE | ID: mdl-35331035

Intracranial atherosclerotic disease (ICAD) is a common cause of acute ischemic stroke. ICAD has a high rate of recurrent ischemic stroke despite recommended adequate medical treatment. Endovascular treatment of ICAD has been controversial due to high periprocedural complication in historic randomized clinical trials (RCTs). Recently, a multicenter prospective study of stent placement in patients with high grade intracranial stenosis that evaluated safety and efficacy of Balloon-mounted stents (BMS) in symptomatic ICAD showed low rates of periprocedural stroke (5.6%) than the SAMMPRIS (14.7%) and VISSIT (21.4%) trials. This review highlights the recent evolution of endovascular therapy for symptomatic ICAD.


Intracranial Arteriosclerosis , Ischemic Stroke , Stroke , Humans , Intracranial Arteriosclerosis/surgery , Intracranial Arteriosclerosis/complications , Angioplasty/methods , Stroke/etiology , Stents/adverse effects , Ischemic Stroke/complications , Treatment Outcome , Multicenter Studies as Topic
...